NCT06671249

Brief Summary

In recent years, laparoscopic breast cancer surgery has received wide attention. It has advantages of minimal invasiveness, clear anatomical exposure, and good aesthetic effects. Based on these advantages, we propose whether laparoscopy is suitable for breast-conserving surgery for breast cancer. The standard procedure of laparoscopic breast-conserving surgery is unclear. More high-quality clinical studies are required. Therefore, we intend to conduct a multi-center, open, productive, randomized controlled study comparing the safety and cosmetic effects of endoscopic breast-conserving with traditional open breast-conserving surgery.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
184

participants targeted

Target at P50-P75 for not_applicable breast-cancer

Timeline
18mo left

Started Oct 2024

Typical duration for not_applicable breast-cancer

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress53%
Oct 2024Oct 2027

First Submitted

Initial submission to the registry

October 23, 2024

Completed
2 days until next milestone

Study Start

First participant enrolled

October 25, 2024

Completed
10 days until next milestone

First Posted

Study publicly available on registry

November 4, 2024

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 25, 2027

Expected
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 25, 2027

Last Updated

November 4, 2024

Status Verified

November 1, 2024

Enrollment Period

2.6 years

First QC Date

October 23, 2024

Last Update Submit

November 1, 2024

Conditions

Keywords

Breast Cancer

Outcome Measures

Primary Outcomes (2)

  • breast appearance satisfaction

    Whether laparoscopic breast-conserving and traditional open breast-conserving had significant differences postoperative cosmetic outcomes. One of the evaluation indicators is breast appearance satisfaction. Our study chooses BREAST-Q questionnaire to evaluate patients' breast appearance satisfaction.

    2 years

  • breast aesthetic scores

    Whether laparoscopic breast-conserving and traditional open breast-conserving had significant differences postoperative cosmetic outcomes. Another of the evaluation indicators is breast aesthetic scores. We will invite two Plastic surgeons who did not participate in the study to judge patients' photographs, which is taken 18 months after the surgery, according to the Harris evaluation criteria.

    2 years

Secondary Outcomes (3)

  • Complications

    1 year

  • Quality of Life

    1 year

  • local recurrence rate

    2 years

Study Arms (2)

Laparoscopic breast-conserving surgery

EXPERIMENTAL

Subjects who is going to accept laparoscopic breast-conserving surgery.

Procedure: Laparoscopic breast-conserving surgery

Traditional open breast-conserving surgery

ACTIVE COMPARATOR

Subjects who is going to accept traditional open breast-conserving surgery.

Procedure: Traditional open breast-conserving surgery

Interventions

Use laparoscopic surgery to treat breast cancer patients who want and have the opportunity to preserve their breast

Laparoscopic breast-conserving surgery

Treat breast cancer patients who want and have the opportunity to preserve their breast with traditional open breast-conserving surgery.

Traditional open breast-conserving surgery

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Female over the age of 18
  • Preoperative pathologically confirmed invasive breast cancer or ductal carcinoma in situ
  • Clinical classification T1, T2 (maximum tumor diameter ≤5cm)
  • Single-center tumor (preoperative confirmation by B-ultrasound, MRI and other imaging examinations)
  • No clinical or imaging evidence of distant metastasis
  • Able and willing to sign informed consent

You may not qualify if:

  • Tumor in the lower inner quadrant
  • Tumor in multiple quadrants
  • Imaging or intraoperative pathology indicates tumor invasion of the nipple areola, skin, or pectoralis major
  • Locally advanced breast cancer patients are undergoing neoadjuvant therapy
  • Tumor in multiple quadrants
  • Have been participating in other clinical trials, which may affect the participation in this trial
  • Previous history of breast cancer (patients with recurrence after ipilateral breast-conserving surgery)
  • Pregnant and lactating women
  • Patients with severe cardiopulmonary disease or severely impaired lung function are not suitable for surgical establishment of an air cavity

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Xiaochen Wang

Hangzhou, Zhejiang, 31000, China

Location

MeSH Terms

Conditions

Breast Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Study Officials

  • Xiaochen - Wang, Doctorate

    Second Affiliated Hospital, School of Medicine, Zhejiang University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Xiaochen - Wang, Doctorate

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 23, 2024

First Posted

November 4, 2024

Study Start

October 25, 2024

Primary Completion (Estimated)

May 25, 2027

Study Completion (Estimated)

October 25, 2027

Last Updated

November 4, 2024

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will not share

Locations